Date: 2026-06-25Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision of the EEA Joint Committee No 73/2026 of 20 March 2026 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/1321]
**Executive Summary**
Decision No 73/2026, adopted on 20 March 2026, amends Annex II (Technical regulations, standards, testing, and certification) to the EEA Agreement to incorporate various EU regulations and decisions concerning biocidal products. The document updates approval statuses, postpones expiry dates for several active substances, and addresses unresolved objections regarding specific product authorisations. The decision is set to enter into force on 21 March 2026, provided all necessary notifications are completed.
**Key Points / Main Content**
**Active Substance Approvals and Renewals**
* **Dazomet:** Formally renews the approval of dazomet as an active substance for use in biocidal products of product-type 8.
* **Repeals:** Repeals Implementing Decision (EU) 2024/2930 concerning the postponement of dazomet's expiry to reflect the new renewal.
**Postponement of Expiry Dates**
The decision incorporates EU measures to extend the approval periods for the following substances:
* **Aluminium phosphide releasing phosphine:** Extended for product-types 14, 18, and 20.
* **Cholecalciferol:** Extended for product-type 14.
* **Lambda-cyhalothrin:** Extended for product-type 18.
* **Magnesium phosphide releasing phosphine:** Extended for product-type 18.
* **Bacillus thuringiensis subsp. israelensis (Strain AM65-52):** Extended for product-type 18.
* **Deltamethrin:** Extended for product-type 18.
**Product Authorisation Objections**
The decision addresses unresolved objections regarding the conditions for granting authorisations for the following specific biocidal products:
* Speed Easy Clean.
* Saltidin 20 % Outdoor.
* ERO MP.
**Legal and Administrative Provisions**
* **Annex II Amendment:** Amends Chapter XV of Annex II to the EEA Agreement by inserting new points (12nnnb to 12nnnl).
* **Language Authenticity:** The texts of the incorporated regulations and decisions in the Icelandic and Norwegian languages are declared authentic.
* **Publication:** The decision will be published in the EEA Section of, and the EEA Supplement to, the Official Journal of the European Union.
**Impact Analysis**
**EEA Member States (Iceland and Norway)**
**Impact**
The national regulatory frameworks of Iceland and Norway are updated to align with European Union standards regarding biocidal products.
**Action Required**
The states must ensure the publication of the authentic Icelandic and Norwegian versions of the incorporated acts and complete the notification requirements under Article 103(1) of the EEA Agreement.
**Manufacturers and Distributors of Biocidal Products**
**Impact**
Companies producing or selling biocidal products containing the listed active substances (e.g., dazomet, deltamethrin, cholecalciferol) gain clarity on extended approval timelines and renewal conditions within the EEA.
**Action Required**
Stakeholders responsible for the products "Speed Easy Clean," "Saltidin 20 % Outdoor," and "ERO MP" must ensure their products meet the specific conditions for authorisation resulting from the resolution of previous objections.
**EEA Joint Committee**
**Impact**
The Committee fulfills its role in maintaining the homogeneity of the EEA Agreement by incorporating recent EU legislative developments.
**Action Required**
Oversee the publication of the decision and monitor the entry into force following constitutional notifications.
Key Entities Referenced
EEA Agreement: The foundational legal framework between the European Union and EFTA states that this decision amends to ensure legislative homogeneity across the European Economic Area.
Regulation (EU) No 528/2012: The primary EU legislative act governing the use and marketing of biocidal products, which provides the legal basis for the specific substance approvals incorporated by this decision.
EEA Joint Committee: The central regulatory body responsible for the administration of the EEA Agreement and the formal adoption of EU laws into the agreement's annexes.
Annex II to the EEA Agreement: The specific policy document section covering technical regulations, standards, testing, and certification that is modified by this decision.
Official Journal EN
of the European Union L series
2026/1321 25.6.2026
DECISION OF THE EEA JOINT COMMITTEENo 73/2026
of 20 March 2026
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
[2026/1321]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98
thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2025/2345 of 19 November 2025 renewing the approval of dazomet as
an active substance for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012
of the European Parliament and of the Council(1)is to be incorporated into the EEA Agreement.
(2) Commission Implementing Decision (EU) 2025/2279 of 13 November 2025 postponing the expiry date of the
approval of aluminium phosphide releasing phosphine for use in biocidal products of product-types 14, 18 and 20
in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(2) is to be
incorporated into the EEA Agreement.
(3) Commission Implementing Decision (EU) 2025/2280 of 13 November 2025 on the unresolved objections regarding
the conditions for granting an authorisation for the biocidal product Speed Easy Clean in accordance with Regulation
(EU) No 528/2012 of the European Parliament and of the Council(3)is to be incorporated into the EEA Agreement.
(4) Commission Implementing Decision (EU) 2025/2282 of 13 November 2025 postponing the expiry date of the
approval of cholecalciferol for use in biocidal products of product-type 14 in accordance with Regulation (EU)
No 528/2012 of the European Parliament and of the Council(4)is to be incorporated into the EEA Agreement.
(5) Commission Implementing Decision (EU) 2025/2283 of 13 November 2025 postponing the expiry date of the
approval of lambda-cyhalothrin for use in biocidal products of product-type 18 in accordance with Regulation (EU)
No 528/2012 of the European Parliament and of the Council(5)is to be incorporated into the EEA Agreement.
(6) Commission Implementing Decision (EU) 2025/2284 of 13 November 2025 postponing the expiry date of the
approval of magnesium phosphide releasing phosphine for use in biocidal products of product-type 18 in
accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(6) is to be
incorporated into the EEA Agreement.
(7) Commission Implementing Decision (EU) 2025/2297 of 13 November 2025 on the unresolved objections regarding
the conditions for granting an authorisation for the biocidal product Saltidin 20 % Outdoor in accordance with
Regulation (EU) No 528/2012 of the European Parliament and of the Council(7)is to be incorporated into the EEA
Agreement.
(8) Commission Implementing Decision (EU) 2025/2309 of 13 November 2025 on the unresolved objections regarding
the conditions for granting an authorisation for the biocidal product ERO MP in accordance with Regulation (EU)
No 528/2012 of the European Parliament and of the Council(8)is to be incorporated into the EEA Agreement.
(1) OJ L, 2025/2345, 20.11.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/2345/oj.
(2) OJ L, 2025/2279, 14.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2279/oj.
(3) OJ L, 2025/2280, 17.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2280/oj.
(4) OJ L, 2025/2282, 17.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2282/oj.
(5) OJ L, 2025/2283, 17.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2283/oj.
(6) OJ L, 2025/2284, 17.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2284/oj.
(7) OJ L, 2025/2297, 17.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2297/oj.
(8) OJ L, 2025/2309, 17.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2309/oj.
ELI: http://data.europa.eu/eli/dec/2026/1321/oj 1/4EN
OJ L, 25.6.2026
(9) Commission Implementing Decision (EU) 2025/2299 of 14 November 2025 postponing the expiry date of the
approval of Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 for use in biocidal products of
product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(9)
is to be incorporated into the EEA Agreement.
(10) Commission Implementing Decision (EU) 2025/2301 of 14 November 2025 postponing the expiry date of the
approval of deltamethrin for use in biocidal products of product-type 18 in accordance with Regulation (EU)
No 528/2012 of the European Parliament and of the Council(10)is to be incorporated into the EEA Agreement.
(11) Commission Implementing Decision (EU) 2025/2344 of 19 November 2025 repealing Implementing Decision
(EU) 2024/2930 postponing the expiry date of the approval of dazomet for use in biocidal products of product-type
8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(11) is to be
incorporated into the EEA Agreement.
(12) Implementing Decision (EU) 2025/2344 repeals Commission Implementing Decision (EU) 2024/2930(12), which is
incorporated into the EEA Agreement and which is consequently to be repealed under the EEA Agreement.
(13) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II to the EEA Agreement is amended as follows:
1. The following points are inserted after point 12nnna (Commission Implementing Decision (EU) 2024/816):
‘12nnnb. 32025 R 2345: Commission Implementing Regulation (EU) 2025/2345 of 19 November 2025
renewing the approval of dazomet as an active substance for use in biocidal products of product-type 8
in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L,
2025/2345, 20.11.2025).
12nnnc. 32025 D 2279: Commission Implementing Decision (EU) 2025/2279 of 13 November 2025
postponing the expiry date of the approval of aluminium phosphide releasing phosphine for use in
biocidal products of product-types 14, 18 and 20 in accordance with Regulation (EU) No 528/2012 of
the European Parliament and of the Council (OJ L, 2025/2279, 14.11.2025).
12nnnd. 32025 D 2280: Commission Implementing Decision (EU) 2025/2280 of 13 November 2025 on the
unresolved objections regarding the conditions for granting an authorisation for the biocidal product
Speed Easy Clean in accordance with Regulation (EU) No 528/2012 of the European Parliament and of
the Council (OJ L, 2025/2280, 17.11.2025).
12nnne. 32025 D 2282: Commission Implementing Decision (EU) 2025/2282 of 13 November 2025
postponing the expiry date of the approval of cholecalciferol for use in biocidal products of product-
type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the
Council (OJ L, 2025/2282, 17.11.2025).
(9) OJ L, 2025/2299, 18.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2299/oj.
(10) OJ L, 2025/2301, 17.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2301/oj.
(11) OJ L, 2025/2344, 20.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2344/oj.
(12) OJ L, 2024/2930, 2.12.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/2930/oj.
2/4 ELI: http://data.europa.eu/eli/dec/2026/1321/ojEN
OJ L, 25.6.2026
12nnnf. 32025 D 2283: Commission Implementing Decision (EU) 2025/2283 of 13 November 2025
postponing the expiry date of the approval of lambda-cyhalothrin for use in biocidal products of
product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of
the Council (OJ L, 2025/2283, 17.11.2025).
12nnng. 32025 D 2284: Commission Implementing Decision (EU) 2025/2284 of 13 November 2025
postponing the expiry date of the approval of magnesium phosphide releasing phosphine for use in
biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European
Parliament and of the Council (OJ L, 2025/2284, 17.11.2025).
12nnnh. 32025 D 2297: Commission Implementing Decision (EU) 2025/2297 of 13 November 2025 on the
unresolved objections regarding the conditions for granting an authorisation for the biocidal product
Saltidin 20 % Outdoor in accordance with Regulation (EU) No 528/2012 of the European Parliament
and of the Council (OJ L, 2025/2297, 17.11.2025).
12nnni. 32025 D 2309: Commission Implementing Decision (EU) 2025/2309 of 13 November 2025 on the
unresolved objections regarding the conditions for granting an authorisation for the biocidal product
ERO MP in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the
Council (OJ L, 2025/2309, 17.11.2025).
12nnnj. 32025 D 2299: Commission Implementing Decision (EU) 2025/2299 of 14 November 2025
postponing the expiry date of the approval of Bacillus thuringiensissubsp. israelensisSerotype H14, Strain
AM65-52 for use in biocidal products of product-type 18 in accordance with Regulation (EU)
No 528/2012 of the European Parliament and of the Council (OJ L, 2025/2299, 18.11.2025).
12nnnk. 32025 D 2301: Commission Implementing Decision (EU) 2025/2301 of 14 November 2025
postponing the expiry date of the approval of deltamethrin for use in biocidal products of product-type
18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ
L, 2025/2301, 17.11.2025).
12nnnl. 32025 D 2344: Commission Implementing Decision (EU) 2025/2344 of 19 November 2025 repealing
Implementing Decision (EU) 2024/2930 postponing the expiry date of the approval of dazomet for use
in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the
European Parliament and of the Council (OJ L, 2025/2344, 20.11.2025).’
2. The text of point 12zzzzzzzzzzzn (Implementing Decision (EU) 2024/2930) is deleted.
Article 2
The texts of Implementing Regulation (EU) 2025/2345 and Implementing Decisions (EU) 2025/2279, (EU) 2025/2280,
(EU) 2025/2282, (EU) 2025/2283, (EU) 2025/2284, (EU) 2025/2297, (EU) 2025/2309, (EU) 2025/2299,
(EU) 2025/2301 and (EU) 2025/2344 in the Icelandic and Norwegian languages, to be published in the EEA Supplement
to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 21 March 2026, provided that all the notifications under Article 103(1) of the EEA
Agreement have been made(*).
(*) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2026/1321/oj 3/4EN
OJ L, 25.6.2026
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European
Union.
Done at Brussels, 20 March 2026.
For the EEA Joint Committee
The President
Nicolas VON LINGEN
4/4 ELI: http://data.europa.eu/eli/dec/2026/1321/oj